Ana Sofia Costa

Biological and clinical characteristics of the European Friedreich's Ataxia Consortium for Translational Studies (EFACTS) cohort: a cross-sectional analysis of baseline data

Kathrin Reetz, Imis Dogan, Ana Sofia Costa et al. · The Lancet Neurology · 2015 · 204 citations

Neurobiology Of Disease, Neuroepidemiology, Ataxia Consortium +8

The Montreal Cognitive Assessment (MoCA) - A Sensitive Screening Instrument for Detecting Cognitive Impairment in Chronic Hemodialysis Patients

Frances Tiffin-Richards, Ana Sofia Costa, Bernhard Holschbach et al. · PLoS ONE · 2014 · 178 citations · Full text

Genotype-specific patterns of atrophy progression are more sensitive than clinical decline in SCA1, SCA3 and SCA6

Kathrin Reetz, Ana Sofia Costa, Shahram Mirzazade et al. · Brain · 2013 · 155 citations · Full text

Neuropsychology, Atrophy Progression, Neurological Disorder +27

Long COVID‐19: Objectifying most self‐reported neurological symptoms

Julia Bungenberg, Karen Humkamp, Christian Hohenfeld et al. · Annals of Clinical and Translational Neurology · 2022 · 129 citations · Full text

Alternate-Form Reliability of the Montreal Cognitive Assessment Screening Test in a Clinical Setting

Ana Sofia Costa, Bruno Fimm, Paul Friesen et al. · Dementia and Geriatric Cognitive Disorders · 2012 · 122 citations